Glooko acquires fellow diabetes administration firm DIABNEXT and extra digital well being briefs


Share post:

Digital diabetes administration firm Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform.

DIABNEXT’s app tracks affected person diabetes metrics, permitting suppliers to observe that information and supply care remotely. Glooko mentioned it’s going to provide its personal platform and DIABNEXT, rebranded as Glooko XT, for the French market.

“We’re more than happy to welcome the DIABNEXT crew to Glooko and particularly excited so as to add their well-regarded product to Glooko’s portfolio, together with their experience within the diabetes neighborhood in France,” Glooko CEO Russ Johannesson mentioned in a press release. 

“The addition of DIABNEXT expands our choices with a novel platform that may assist us higher customise the affected person expertise and enhance well being outcomes for individuals with diabetes. Glooko’s acquisition of DIABNEXT additional cements our dedication to extend our world presence and proceed to drive progressive options.”

That is Glooko’s second acquisition this yr. In January, the corporate introduced it had bought Berlin-based xbird, maker of AI-based diabetes care instruments. The corporate raised $30 million in Sequence D funding final yr. 

Papa, which gives in-home help for seniors or different weak populations, introduced Wednesday it is increasing into the employer market.

The startup mentioned partnerships with employers will present caregiving help for employees who should help aged, chronically in poor health or disabled relations along with their paid work. 

“For workers, the not possible balancing act between one’s work and household roles impacts them, their dependents, and in the end their employer,” Andrew Parker, founder and CEO of Papa, mentioned in a press release.

“Papa has proven success with Medicare Benefit and Medicaid members when it comes to decreased loneliness and improved well being, and we imagine there may be large alternative to increase our mannequin to versatile household care, for assist when, the place, and the way it’s most wanted.”

In late 2021, Papa scooped up $150 million in Sequence D funding.

Digital chronic-condition administration firm Lark Well being is growing an AI-enabled platform for stopping and managing atherosclerotic heart problems (ASCVD) and coronary artery illness (CAD) in partnership with Roche Diagnostics.

The Lark Coronary heart Well being program, which is ready to launch later this yr, makes use of the ideas of cognitive behavioral remedy to supply teaching round wholesome behaviors and lowering stress. 

“Lark Coronary heart Well being will assist these at excessive danger forestall and actively handle heart problems by customized digital teaching,” cofounder and CEO Julia Hu mentioned in a press release. “By leveraging our AI expertise, we will ship significant and interesting care at an unprecedented scale, and this collaboration with Roche Diagnostics will help the growth of our confirmed tech platform into one of many costliest power illness markets.”

Supply hyperlink


Please enter your comment!
Please enter your name here


Related articles